Statement by WuXi AppTec Regarding Recent Market Fluctuation
SHANGHAI, Dec. 16, 2021 /PRNewswire/ -- Our company's activities continue apace and we remain confident in our platform, which enables our global customers and serves patients around the world. We will provide any new information as warranted and in compliance with applicable laws and regulations. View original content:https://www.prnewswire.com/news-releases/statement-by-wuxi-apptec-regarding-recent-market-fluctuation-301445967.html
CSafe Global Announces Acquisition of Softbox Systems to Create the Global Leader in Temperature-Controlled Shipping Solutions
DAYTON, Ohio and LONG CRENDON, Buckinghamshire, England, Dec. 15, 2021 /PRNewswire/ -- CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced today that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, significantly enhancing CSafe's...
SQREEM’s New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US
NEW YORK, Dec. 15, 2021 /PRNewswire/ -- COVID-19 vaccines have once again become a hot topic in the United States as President Joe Biden pushes on with vaccination mandates in a bid to manage concerns around the Omicron variant ahead of the winter flu season. Despite vaccination rates reaching 60%, vaccination coverage remains uneven across the fifty states, with...
Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine
NEW BRUNSWICK, N.J., Dec. 15, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a Positive Opinion for use of the Company's COVID-19 vaccine as a booster for adults aged 18 and older...
MISS UNIVERSE INDIA, HARNAAZ SANDHU, CROWNED 70TH MISS UNIVERSE WITH THE ICONIC MOUAWAD “POWER OF UNITY” CROWN IN GLOBAL ANNIVERSARY TELEVISION EVENT
Fourth generation Mouawad Co-Guardians Fred, Alain and Pascal Mouawad commented the crowning moment DUBAI, UAE, Dec. 15, 2021 /PRNewswire/ -- Miss Universe India Harnaaz Sandhu was crowned Miss Universe live on FOX and Telemundo tonight from Eilat, Israel. Harnaaz will use her time as Miss Universe to advocate for menstrual equity through public administration. Power of...
FDA Breakthrough Devices Designation Application to Fast-Track Painful Finger-Prick Alternative for People Living with Diabetes
SYDNEY, Dec. 15, 2021 /PRNewswire/ -- Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company and subsidiary of The iQ Group Global, announced it has filed an application with the U.S Food and Drug Administration (FDA) for Breakthrough Devices Designation for its Saliva Glucose Biosensor. Image: https://distribution.medianet.com.au/Download/Document?j=964158&s=2&k=2100471 The FDA Program will provide LSBD...
I-Mab Receives IND Approval for Phase 1 Clinical Trial of Bispecific Antibody TJ-CD4B in Solid Tumors in China
SHANGHAI and GAITHERSBURG, Md., Dec. 15, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved the IND submission for the initiation of a phase...
A Record Year for ZEISS
OBERKOCHEN, Germany, Dec. 15, 2021 /PRNewswire/ -- The ZEISS Group ended fiscal year 2020/21 (end of reporting period: 30 September 2021) on an excellent note: its revenue rose by 20% to 7.529 billion euros (previous year: 6.297 billion euros). Over 90% of this sum was generated in markets outside Germany. Earnings before interest and tax (EBIT) also achieved a...
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca’s portfolio
- Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to AstraZeneca's portfolio in Q1 2021 LONDON, Dec. 15, 2021 /PRNewswire/ -- BenevolentAI, a leading clinical-stage...
MGI Contributes to Rapid Detection and Surveillance of COVID-19 Omicron Variant
SHENZHEN, China, Dec. 15, 2021 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a global life science leader and innovator, is playing an instrumental role in the global battle against the omicron variant of COVID-19 with its DNBSEQ™ and ATOPlex technologies. As a responsible global company, and as omicron begins to rapidly spread around the world, MGI's innovative equipment has...
